The Power of AVA
AEGEA Medical’s Adaptive Vapor Advantage (AVA™) technology is venture-backed and is currently being evaluated in an international pivotal clinical trial under an Investigational Device Exemption (IDE) approved by the U.S. Food and Drug Administration (FDA).
Harnessing a Natural Energy
The concept behind AVA technology is simple – water vapor efficiently enables the body to naturally eliminate unwanted tissue. By combining the power of pure water vapor with the body’s natural healing response, AVA technology provides an opportunity to deliver safe and effective treatment options for a variety of women’s health conditions.
AVA technology harnesses water vapor for targeted delivery within the body. By efficiently converting small amounts of sterile water into naturally expansive vapor and delivering it via a controlled, low-pressure system, AVA technology offers innovative possibilities for treating the unique anatomical differences found in women.
The Science Behind AVA
Our innovative technology begins with sterile water that is heated, converted to vapor (water in gas form), and delivered to designated treatment areas using a controlled, low-pressure system. As the delivered vapor condenses back to a liquid state, stored thermal energy is released, causing affected cell membranes to ablate. Instinctively, the body’s natural healing response then eliminates the treated tissue.
We believe AVA technology offers a unique and efficient means for thermal energy transfer. AVA technology is currently being assessed for treatment of abnormal uterine bleeding using the AEGEA Vapor System. The AEGEA Vapor System is not commercially available in the United States. The above assumptions are currently being studied under an Investigational Device Exemption (IDE) approved by the FDA.